A new HIV vaccine has generated powerful broadly neutralizing antibodies in animal studies and has now entered human trials, ...

Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

LJI Instructor Dr. Patrick Madden said the team wants to see antibody response in 100% of the animals, not just 44%.

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about ...

After decades of failed HIV vaccines, a new approach that predicts which cells to train, not just what antigen to show, has ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A supercharged HIV vaccine could offer strong protection with just one ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional ...

Share on Pinterest The Trump administration’s plan to cut funding for HIV vaccine research comes at a time when the field is making progress. Victor Torres/Stocksy United The Trump administration ...

An experimental HIV vaccine candidate developed by LJI, Scripps Research and IAVI generated high levels of broadly ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

A new experimental HIV vaccine has generated high levels of broadly neutralising antibodies in non-human primates, marking ...